Literature DB >> 24024514

Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology.

Eduardo Anitua1, Roberto Prado, Gorka Orive.   

Abstract

The goal of this Review is to provide an overview of the cell culture media supplements used in the ex vivo expansion of stem cells intended for cell therapy. Currently, the gold standard is the culture supplemented with fetal bovine serum, however, their use in cell therapy raises many concerns. The alternatives to its use are presented, ranging from the use of human serum to platelet-rich plasma (PRP), to serum-free media or extracellular matrix components. Finally, various growth factors present in PRP are described, which make it a safe and effective stem cell expansion supplement. These growth factors could be responsible for their efficiency, as they increase both stem cell proliferation and survival. The different PRP formulations are also discussed, as well as the need for protocol standardization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24024514     DOI: 10.4155/tde.13.68

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  6 in total

Review 1.  Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization.

Authors:  Eduardo Anitua; Mar Zalduendo; Maria Troya; Mohammad H Alkhraisat; Leticia Alejandra Blanco-Antona
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

2.  Investigation of modified platelet-rich plasma (mPRP) in promoting the proliferation and differentiation of dental pulp stem cells from deciduous teeth.

Authors:  J Wen; H T Li; S H Li; X Li; J M Duan
Journal:  Braz J Med Biol Res       Date:  2016-09-01       Impact factor: 2.590

3.  The Effects of Platelet-Rich and Platelet-Poor Plasma on Biological Characteristics of BM-MSCs In Vitro.

Authors:  Jiahui Zhang; Jun Zhang; Nannan Zhang; Tao Li; Xiaohe Zhou; Jue Jia; Yingying Liang; Xiaochun Sun; Huabiao Chen
Journal:  Anal Cell Pathol (Amst)       Date:  2020-08-26       Impact factor: 2.916

4.  Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.

Authors:  José María Lamo-Espinosa; Juan F Blanco; Mikel Sánchez; Victoria Moreno; Froilán Granero-Moltó; Fermín Sánchez-Guijo; Íñigo Crespo-Cullel; Gonzalo Mora; Diego Delgado San Vicente; Orlando Pompei-Fernández; Jesús Dámaso Aquerreta; Jorge María Núñez-Córdoba; María Vitoria Sola; Andrés Valentí-Azcárate; Enrique J Andreu; María Del Consuelo Del Cañizo; Juan Ramón Valentí-Nin; Felipe Prósper
Journal:  J Transl Med       Date:  2020-09-18       Impact factor: 5.531

5.  Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.

Authors:  Elżbieta Cecerska-Heryć; Rafał Heryć; Grażyna Dutkiewicz; Anna Michalczyk; Bartłomiej Grygorcewicz; Natalia Serwin; Sylwia Napiontek-Balińska; Barbara Dołęgowska
Journal:  BMC Nephrol       Date:  2022-01-18       Impact factor: 2.388

6.  Application effect of lattice laser in facial rejuvenation: A protocol for systematic review and meta-analysis.

Authors:  Dan Yan; Zechun Huang; Anli Zhang; Shuaihua Li; Yao Xiao
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.